Targeting protein modification: a new direction for immunotherapy of pancreatic cancer
- PMID: 39744438
- PMCID: PMC11667816
- DOI: 10.7150/ijbs.101861
Targeting protein modification: a new direction for immunotherapy of pancreatic cancer
Abstract
Post-translational modifications (PTMs) alter protein conformation by covalently attaching functional groups to substrates, influencing their biological activity, mechanisms of action, and functional performance. PTMs and their interactions are essential to many critical signal transduction processes, including tumor transformation, cancer progression, and metastasis in pancreatic cancer. Additionally, advancements in tumor immunotherapy indicate that PTMs are essential in immune cell activation, transport, and energy metabolism. This study aimed to investigate the effects of different PTMs on immunotherapy for pancreatic cancer, providing new perspectives and suggesting directions for future research.
Keywords: Immune escape; Immunotherapy; Pancreatic cancer; Post-translational modifications; Targeted therapy.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
Similar articles
-
Advances in post-translational modifications of proteins and cancer immunotherapy.Front Immunol. 2023 Aug 22;14:1229397. doi: 10.3389/fimmu.2023.1229397. eCollection 2023. Front Immunol. 2023. PMID: 37675097 Free PMC article. Review.
-
Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.Dig Dis Sci. 2021 Feb;66(2):359-368. doi: 10.1007/s10620-020-06183-9. Epub 2020 Mar 5. Dig Dis Sci. 2021. PMID: 32140943 Review.
-
Novel post-translational modifications of protein by metabolites with immune responses and immune-related molecules in cancer immunotherapy.Int J Biol Macromol. 2024 Oct;277(Pt 1):133883. doi: 10.1016/j.ijbiomac.2024.133883. Epub 2024 Jul 19. Int J Biol Macromol. 2024. PMID: 39033895 Review.
-
Role of UFMylation in tumorigenesis and cancer immunotherapy.Front Immunol. 2024 Aug 23;15:1454823. doi: 10.3389/fimmu.2024.1454823. eCollection 2024. Front Immunol. 2024. PMID: 39247188 Free PMC article. Review.
-
Complex role for the immune system in initiation and progression of pancreatic cancer.World J Gastroenterol. 2014 Aug 28;20(32):11160-81. doi: 10.3748/wjg.v20.i32.11160. World J Gastroenterol. 2014. PMID: 25170202 Free PMC article. Review.
Cited by
-
In situ thermal-responsive hydrogels for combined photothermal therapy and chemotherapy of pancreatic cancer.RSC Adv. 2025 Apr 24;15(17):13119-13126. doi: 10.1039/d5ra00371g. eCollection 2025 Apr 22. RSC Adv. 2025. PMID: 40275869 Free PMC article.
References
-
- Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605–17. - PubMed
-
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. - PubMed
-
- Strobel O, Neoptolemos J, Jäger D, Büchler MW. Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol. 2019;16:11–26. - PubMed
-
- Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15:333–48. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
